Search research articles
Contact Us
Filters
Showing results (271-280 of 328) with videos related to
Page
of 33
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2014
Transient MEK inhibitor-associated retinopathy in metastatic melanoma
U Urner-Bloch, M Urner, P Stieger, et al.
Cancer
|
October 24, 2000
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma
L M Heinzerling, M Urbanek, J O Funk, et al.
Journal of Cutaneous Pathology
|
February 1, 1995
Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates
R Dummer, S A Michie, D Kell, et al.
The British Journal of Dermatology
|
July 1, 2014
Basal cell carcinomas in a tertiary referral centre: a systematic analysis
J Dreier, P F Cheng, I Bogdan Alleman, et al.
British Journal of Cancer
|
August 26, 2010
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
J C Hassel, A Sucker, L Edler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2009
Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma
K Strobel, B Bode, R Dummer, et al.
Biomed Research International
|
August 21, 2019
Erratum to "Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma"
A Curioni-Fontecedro, R Pitocco, N L Schoenewolf, et al.
Biomed Research International
|
July 11, 2015
Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma
A Curioni-Fontecedro, R Pitocco, N L Schoenewolf, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
December 26, 2001
Expression of TCL1 in hematologic disorders
J Roos, I Hennig, J Schwaller, et al.
Cancer
|
February 15, 1995
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring
R Dummer, M E Gore, B W Hancock, et al.
Page
of 33
Search research articles
Search
Showing results (271-280 of 328) with videos related to
Sort By:
Page
of 33
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2014
Transient MEK inhibitor-associated retinopathy in metastatic melanoma
U Urner-Bloch, M Urner, P Stieger, et al.
Cancer
|
October 24, 2000
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma
L M Heinzerling, M Urbanek, J O Funk, et al.
Journal of Cutaneous Pathology
|
February 1, 1995
Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates
R Dummer, S A Michie, D Kell, et al.
The British Journal of Dermatology
|
July 1, 2014
Basal cell carcinomas in a tertiary referral centre: a systematic analysis
J Dreier, P F Cheng, I Bogdan Alleman, et al.
British Journal of Cancer
|
August 26, 2010
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
J C Hassel, A Sucker, L Edler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2009
Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma
K Strobel, B Bode, R Dummer, et al.
Biomed Research International
|
August 21, 2019
Erratum to "Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma"
A Curioni-Fontecedro, R Pitocco, N L Schoenewolf, et al.
Biomed Research International
|
July 11, 2015
Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma
A Curioni-Fontecedro, R Pitocco, N L Schoenewolf, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
December 26, 2001
Expression of TCL1 in hematologic disorders
J Roos, I Hennig, J Schwaller, et al.
Cancer
|
February 15, 1995
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring
R Dummer, M E Gore, B W Hancock, et al.
Page
of 33